Dukes I D, Vaughan Williams E M
J Physiol. 1984 Oct;355:523-46. doi: 10.1113/jphysiol.1984.sp015436.
Selective adrenoceptor agonists and antagonists have been used to analyse the effects of stimulation of individual types of adrenoceptor in various parts of the rabbit heart. The selective alpha 1- and alpha 2-adrenoceptor agonists used were St 587 and BHT 933 respectively, and the antagonists were prazosin (alpha 1) and WY 25309 (alpha 2). The selective beta 1- and beta 2-adrenoceptor antagonists were atenolol and ICI 118551, respectively. Pirbuterol was a highly selective beta 2-adrenoceptor agonist. The non-selective agonists noradrenaline, adrenaline and isoprenaline were also employed with various combinations of antagonists. Phenylephrine was found to stimulate beta- as well as alpha-adrenoceptors. Rimiterol was a beta-adrenoceptor agonist, partially selective for beta 2-adrenoceptors. In the sinus node beta 1-, but not beta 2-adrenoceptor stimulation increased the fast phase of depolarization (Vmax). Both beta 1- and beta 2-adrenoceptor stimulation increased the slope of slow diastolic depolarization, accelerated repolarization and increased maximum diastolic potential. After blockade of both beta 1- and beta 2-adrenoceptors alpha 1-adrenoceptor stimulation caused bradycardia, due exclusively to delayed repolarization. alpha 2-adrenoceptor stimulation had no effect. In Purkinje cells and papillary muscle both beta 1- and beta 2-adrenoceptor stimulation accelerated repolarization. Stimulation of alpha 2-adrenoceptors had no effect. Beta 1-, not beta 2-adrenoceptor stimulation augmented peak contractions 3-5-fold, and greatly increased rate of development of tension. After beta-blockade alpha 1-adrenoceptor stimulation moderately increased peak contractions (up to 47%), but increased time-to-peak and duration of contractions. These patterns of adrenoceptor-mediated effects were unchanged in animals pre-treated with sufficient 6-hydroxydopamine to eliminate responses to sympathetic nerve stimulation. The results would be consistent with beta 1-, and beta 2-adrenoceptor stimulation increasing inward calcium current, and with stimulation of alpha 1-adrenoceptors delaying its inactivation, rather than increasing its magnitude.
选择性肾上腺素能受体激动剂和拮抗剂已被用于分析刺激兔心脏各部位不同类型肾上腺素能受体的效应。所使用的选择性α1和α2肾上腺素能受体激动剂分别为St 587和BHT 933,拮抗剂分别为哌唑嗪(α1)和WY 25309(α2)。选择性β1和β2肾上腺素能受体拮抗剂分别为阿替洛尔和ICI 118551。吡布特罗是一种高度选择性的β2肾上腺素能受体激动剂。非选择性激动剂去甲肾上腺素、肾上腺素和异丙肾上腺素也与各种拮抗剂组合使用。发现去氧肾上腺素可刺激β以及α肾上腺素能受体。利米特罗是一种β肾上腺素能受体激动剂,对β2肾上腺素能受体有部分选择性。在窦房结,刺激β1而非β2肾上腺素能受体可增加去极化的快速相(Vmax)。刺激β1和β2肾上腺素能受体均增加舒张期缓慢去极化的斜率,加速复极化并增加最大舒张电位。在阻断β1和β2肾上腺素能受体后,刺激α1肾上腺素能受体导致心动过缓,完全是由于复极化延迟。刺激α2肾上腺素能受体无作用。在浦肯野细胞和乳头肌中,刺激β1和β2肾上腺素能受体均加速复极化。刺激α2肾上腺素能受体无作用。刺激β1而非β2肾上腺素能受体使峰值收缩增强3至5倍,并大大增加张力发展速率。β受体阻断后,刺激α1肾上腺素能受体适度增加峰值收缩(高达47%),但增加了达到峰值的时间和收缩持续时间。在用足够的6-羟基多巴胺预处理以消除对交感神经刺激的反应的动物中,这些肾上腺素能受体介导的效应模式未改变。结果与β1和β2肾上腺素能受体刺激增加内向钙电流一致,与刺激α1肾上腺素能受体延迟其失活而非增加其幅度一致。